277 related articles for article (PubMed ID: 3157214)
1. [Tumoral hypercalcemia: physiopathology and treatment].
Rizzoli R; Jung A; Bonjour JP
Schweiz Med Wochenschr; 1985 Mar; 115(10):326-32. PubMed ID: 3157214
[TBL] [Abstract][Full Text] [Related]
2. Hypercalcemia.
Bilezikian JP
Curr Ther Endocrinol Metab; 1994; 5():511-4. PubMed ID: 7704784
[No Abstract] [Full Text] [Related]
3. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
Buchs B; Rizzoli R; Bonjour JP
Bone; 1991; 12(1):47-56. PubMed ID: 2054236
[TBL] [Abstract][Full Text] [Related]
4. Therapy of malignancy-associated hypercalcemia: 1983.
Stewart AF
Am J Med; 1983 Mar; 74(3):475-80. PubMed ID: 6219580
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis and management of cancer associated hypercalcaemia.
Ralston SH
Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
[TBL] [Abstract][Full Text] [Related]
6. Hypercalcemia of malignancy: diagnosis and therapy.
Fetchick DA; Mundy GR
Compr Ther; 1986 Aug; 12(8):27-32. PubMed ID: 2943551
[TBL] [Abstract][Full Text] [Related]
7. Hypercalcaemia due to malignancy. Role of the kidney and treatment.
Sleeboom HP; Bijvoet OL
Contrib Nephrol; 1982; 33():178-96. PubMed ID: 6214375
[No Abstract] [Full Text] [Related]
8. Drug therapy of hypercalcemia due to malignancy.
Raue F; Pecherstorfer M
Recent Results Cancer Res; 1994; 137():138-60. PubMed ID: 7878293
[No Abstract] [Full Text] [Related]
9. [Treatment of malignancy-associated hypercalcemia].
Endo I; Inoue D
Clin Calcium; 2006 Apr; 16(4):665-69. PubMed ID: 16582519
[TBL] [Abstract][Full Text] [Related]
10. Is there a role for parathyroid hormone in humoral hypercalcemia of malignancy?
Stewart AF
Miner Electrolyte Metab; 1982; 8(3-4):215-26. PubMed ID: 6300632
[No Abstract] [Full Text] [Related]
11. Normocalcemic primary hyperparathyroidism: resistance to PTH effect on tubular reabsorption of calcium.
Gardin JP; Paillard M
Miner Electrolyte Metab; 1984; 10(5):301-8. PubMed ID: 6493158
[TBL] [Abstract][Full Text] [Related]
12. Hypercalcemia: diagnosis and therapy.
Canalis EM; Mundy GR; Raisz LG
Conn Med; 1977 Jan; 41(1):16-21. PubMed ID: 137799
[No Abstract] [Full Text] [Related]
13. The hypercalcemia of malignancy: pathogenesis and management.
Mundy GR; Martin TJ
Metabolism; 1982 Dec; 31(12):1247-77. PubMed ID: 6755168
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcemic crisis.
O'Dorisio TM
Heart Lung; 1978; 7(3):425-34. PubMed ID: 148440
[No Abstract] [Full Text] [Related]
15. [Extraparathyroid hypercalcemia].
Rizzoli R; Bonjour JP
Rev Prat; 1998 Jun; 48(11):1197-200. PubMed ID: 9781171
[TBL] [Abstract][Full Text] [Related]
16. Medical management of the hypercalcemia of malignancy.
Deftos LJ; Neer R
Annu Rev Med; 1974; 25(0):323-31. PubMed ID: 4277568
[No Abstract] [Full Text] [Related]
17. Acute management of cancer-related hypercalcemia.
Chisholm MA; Mulloy AL; Taylor AT
Ann Pharmacother; 1996 May; 30(5):507-13. PubMed ID: 8740333
[TBL] [Abstract][Full Text] [Related]
18. Gallium nitrate for treatment of refractory hypercalcemia from parathyroid carcinoma.
Warrell RP; Issacs M; Alcock NW; Bockman RS
Ann Intern Med; 1987 Nov; 107(5):683-6. PubMed ID: 2821862
[TBL] [Abstract][Full Text] [Related]
19. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
[TBL] [Abstract][Full Text] [Related]
20. The effect of low calcium diet, mithramycin, and dichlorodimethylene bisphosphonate on humoral hypercalcemia of malignancy in nude mice transplanted with the canine adenocarcinoma tumor line (CAC-8).
Rosol TJ; Capen CC
J Bone Miner Res; 1987 Oct; 2(5):395-405. PubMed ID: 2971305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]